Your browser doesn't support javascript.
loading
Can HALP score predict post-contrast acute kidney injury and 6-year mortality in patients undergoing endovascular abdominal aneurysm repair?
Özderya, Ahmet; Sahin, Sinan; Kosmaz, Tolga; Maz, Mehmet Ali; Yerlikaya, Murat Gökhan; Akyüz, Ali Riza; Sayin, Muhammet Rasit; Erkan, Hakan.
Afiliação
  • Özderya A; Department of Cardiology, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey.
  • Sahin S; Department of Cardiology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
  • Kosmaz T; Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
  • Maz MA; Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
  • Yerlikaya MG; Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
  • Akyüz AR; Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
  • Sayin MR; Department of Cardiology, University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey.
  • Erkan H; Department of Cardiology, University of Health Science Bursa City Hospital, Bursa, Turkey.
Vascular ; : 17085381241246905, 2024 Apr 12.
Article em En | MEDLINE | ID: mdl-38607832
ABSTRACT

BACKGROUND:

The aim of this study is to investigate the relationship between HALP score and post-contrast acute kidney injury (PC-AKI) and average 6-year mortality in patients undergoing endovascular abdominal aortic aneurysm repair (EVAR).

METHODS:

125 patients who underwent EVAR between January 2015 and December 2020 were included in our study. HALP score was calculated with the formula "hemoglobin × albumin × lymphocyte count/platelet count." In the first phase of the study, two groups were developed those who developed PC-AKI and those who did not. In the second stage, statistical analysis was performed by creating two groups average 6-year mortality and survivors group.

RESULTS:

HALP score was found to be lower in the PC-AKI group [26.12 (14-61.54) versus 40.53 (7.22-103.61); p < .001]. Low HALP score was found to be both a dependent and independent predictor of the development of PC-AKI (p = .019). HALP score was also found to be lower in the mortality group compared to the survivors [28.97 (12.6-103.61) versus 40.81 (7.22-99) p = .004]. Low HALP score was found to be only a dependent predictor of mortality. The development of PC-AKI was found to be an independent predictor of mortality (p = .042).

CONCLUSIONS:

The HALP score, which can be calculated with a simple formula, can be used to predict PC-AKI and medium-long-term mortality in EVAR patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vascular Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vascular Ano de publicação: 2024 Tipo de documento: Article